Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:06:28.113Z.
Calculation as of: 2026-10-06T14:06:28.113Z.
Quote observation: 2026-10-06T14:04:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b5b90a83151b8a074e07f32cd5a8423240b7dae761ecc8f52934664174c7f924
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$36.32M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.45M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.64M
Free Cash Flow Yield
N/A
TTM Avg
11.85%
3Y Avg
7.93%
5Y Avg
7.46%
Market Cap
$34.44M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.60M
Free Cash Flow Yield
N/A
TTM Avg
18.27%
3Y Avg
9.27%
5Y Avg
7.40%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $35.82M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.45M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $36.64M | N/A | 11.85% | 7.93% | 7.46% |
| DocGo Inc. (DCGO)vs › | $36.70M | N/A | 46.18% | 39.12% | 25.79% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.60M | N/A | 18.27% | 9.27% | 7.40% |
| Incannex Healthcare Limited (IXHL)vs › | $38.82M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
116.01%
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
